FM
Frank Mulindwa

Publications (9)

Association between biomarkers of inflammation and dyslipidemia in drug resistant tuberculosis in Uganda
Article scientifique · 2024
Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report
Article scientifique · 2023
Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults
Article scientifique · 2023
Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? A case report
Article scientifique · 2023
Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks
Article scientifique · 2023
Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults
Article scientifique · 2023
Time to blood pressure control and predictors among patients receiving integrated treatment for hypertension and HIV based on an adapted WHO HEARTS implementation strategy at a large urban HIV clinic in Uganda
Article scientifique · 2023
Blood glucose trajectories and incidence of diabetes mellitus in Ugandan people living with HIV initiated on dolutegravir
Article scientifique · 2023
Adoption of evidence-informed guidelines in prescribing protease inhibitors for HIV-Tuberculosis co-infected patients on rifampicin and effects on HIV treatment outcomes in Uganda
Article scientifique · 2021

Domaines principaux

Sciences de la santé9

Statistiques

Consultations7
Téléchargements0